Important Message – Fraud Alert We have been made aware of fraudulent messages impersonating our company.
Michael Cintolo photo

STOCKS

Michael Cintolo

Vice President of Investments and Chief Analyst,

Cabot Heritage Corporation

  • Chief Analyst of Cabot Growth Investor & Cabot Top Ten Trader
  • Uncovered Exceptional Growth Stocks
  • Helped to Create New Tools & Rules for Buying & Selling Stocks.

About Michael

During his more than ten years at Cabot, Michael Cintolo has uncovered exceptional growth stocks and helped to create new tools and rules for buying and selling stocks. Perhaps most notable was his development of the proprietary trend-following market timing system, Cabot Tides, which has helped Cabot place among the top investment newsletters numerous times. Cabot Growth Investor has been consistently recognized for outstanding performance by Hulbert Financial Digest and Timer Digest. It is one of Hulbert's top five newsletters for five-year risk-adjusted performance with a 13.2% annualized return as of June 30, 2011. It is also ranked among the Top Ten Newsletters by Timer Digest for long-term performance.

Michael's Articles

July was a dreadful month for growth stocks and indexes, with things like the IBD 50 Index and the iShares MSCI USA Momentum Fund (MTUM) off well over 10%. But I still like Guardant Health Inc. (GH), which has only retreated to its 50-day line on modest volume, notes Mike Cintolo, editor of Cabot Growth Investor.
We continue to see and hear about many uncertainties, not the least of which is the continued back-and-forth in the Middle East. Despite that, stocks have continued to handle themselves very well. Our top trade is Twilio Inc. (TWLO), which has solid growth and free cash flow. The stock also just emerged from a huge base after earnings, explains Mike Cintolo, editor of Cabot Top Ten Trader.
Ciena Corp. (CIEN) makes advanced modems, routers, and other systems for large enterprises in cloud, 5G, data center, and Internet of Things. CIEN broke out in September and has had a humongous run since. But like a few later-stage AI names, it continues to look like it wants to move up from here — if the market allows it, explains Mike Cintolo, editor of Cabot Top Ten Trader.
Axsome Therapeutics Inc. (AXSM) is a name we started to follow just as the market was going over the falls in early 2025. As opposed to the market, the stock stayed down for months afterward. But after a lot of base-building, buyers have taken control and the growth and the story are as good as ever, advises Mike Cintolo, chief investment strategist at Cabot Wealth Network.

Michael's Videos

Now, at mid-year, Mike Cintolo highlights some of the best performers and their current outlook on these Top Picks: Arista Networks.